Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia [NA]

View source ↗

Summary

A clinical trial evaluating ultrasonic neuromodulation of the cingulate cortex for fibromyalgia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ultrasonic Neuromodulation Device (Cingulate Cortex)

Snippet

Sponsor: SPIRE Therapeutics Inc. | Conditions: Fibromyalgia | NA | Status: RECRUITING